Primary Record
Famitinib
- In stock
- 3,035 g
- Purity
- 99.1 %
- CAS
- 1044040-56-3
Compound Identifiers & Properties
- CAS
- 1044040-56-3
- PubChem CID
- 16662431
- SMILES
- CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)/C=C\3/C4=C(C=CC(=C4)F)NC3=O)C
- Canonical SMILES
- CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O
Names & Synonyms
- Famitinib
- Famitinib, (Z)
- (Z)-Famitinib
- Abit (China)
- Famitinib (Standard)
- SHR-1020
- SHR1020
- starbld0044024
- FAMITINIB [INN]
- 1044040-56-3
- RefChem:139914
- Famitinib (SHR1020)
- D0Z6MT
- UNII-768FW21J3L
- FAMITINIB [WHO-DD]
- 768FW21J3L
- CHEMBL1278146
- SCHEMBL137251
- GTPL7886
- orb1685248
- DTXSID301358976
- EX-A6762
- SHR 1020
- BDBM50331023
- compound 9 [PMID: 21028894]
- DB11741
- HY-108713R
- DA-63367
- MS-27081
- NS00072868
- Receptor tyrosine kinase inhibitors (cancer)
- J3.407.690A
- G14485
- 945380-27-8
- A1009149
- Q27077275
- 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4-one
- Tyrosine-kinase inhibitor (oral, cancer), Jiangsu Hengrui
- Receptor tyrosine kinase inhibitors (cancer), Shanghai Hengrui
- 4H-PYRROLO(3,2-C)PYRIDIN-4-ONE, 5-(2-(DIETHYLAMINO)ETHYL)-2-((5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-1,5,6,7-TETRAHYDRO-3-METHYL-
- 5-(2-(diethylamino)ethyl0-2-9(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1H-pyrrolo(3,2-c)pyridin-4(5H)-one
- C-Kit/VEGFR2/PDGFR/VEGFR3/Flt1/Flt3 inhibitor (oral, cancer), Jiangsu Hengrui
- (3Z)-3-((5-(2-(diethylamino)ethyl)-3-methyl-4-oxo-1H,4H,5H,6H,7H-pyrrolo(3,2-c)pyridin-2-yl)methylidene)-5-fluoro-2,3-dihydro-1H-indol-2-one
- (3Z)-3-({5-[2-(diethylamino)ethyl]-3-methyl-4-oxo-1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridin-2-yl}methylidene)-5-fluoro-2,3-dihydro-1H-indol-2-one
- (Z)-2-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-5-(2-diethylaminoethyl)-3-methyl-1,5,6,7-tetrahydropyrrolo-[3,2-c]pyridin-4-one
- (Z)-5-(2-(DIETHYLAMINO)ETHYL)-2-((5-FLUORO-2-OXOINDOLIN-3-YLIDENE)METHYL)-3-METHYL-6,7-DIHYDRO-1H-PYRROLO(3,2-C)PYRIDIN-4(5H)-ONE
- (Z)-5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one
- 4H-PYRROLO(3,2-C)PYRIDIN-4-ONE, 5-(2-(DIETHYLAMINO)ETHYL)-2-((Z)-(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-1,5,6,7-TETRAHYDRO-3-METHYL-
- 5-(2-(Diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- 5-(2-(Diethylamino)ethyl)-2-((Z)-5-fluoro-2-oxoindoline-3-ylidene)methyl-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridine-4(5H)-one
- 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one
- 5-(2-diethylaminoethyl)-2-((Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1H-pyrrolo(4,5-c)pyridin-4-one
- 5-(2-diethylaminoethyl)-2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1H-pyrrolo[4,5-c]pyridin-4-one
- 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-3-methyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1);Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1)